ELAN vs IQV · rev $2.74B vs P/E 23, rev $16.31B
Elanco Animal Health (ELAN) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
ELAN currently screens at market cap $11.80B. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the ELAN and IQV stock pages for the full models.
Not investment advice.